Patents by Inventor Petrus Herman Maria Van Der Putten

Petrus Herman Maria Van Der Putten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040055026
    Abstract: There is provided the use of a metabotropic glutamate receptor mGluR7 agonist for the facilitation of neurotransmitter release from a nerve ending and the treatment of neurological conditions, including epilepsy. Moreover, the invention provides transgenic knockout non-human mammals lacking the mGluR7 gene, suitable for studying mGluR7 and modulators thereof as well as epilepsy.
    Type: Application
    Filed: March 4, 2003
    Publication date: March 18, 2004
    Inventor: Petrus Herman Maria van der Putten
  • Patent number: 6566580
    Abstract: The use of a metabotropic glutamate receptor mGluR7 agonist for the facilitation of neurotransmitter release from a nerve ending and the treatment of neurological conditions, including epilepsy. Transgenic knockout non-human mammals are provided which lack the mGluR7 gene, suitable for studying mGluR7 and modulators thereof as well as epilepsy. Specifically provided is a transgenic mouse homozygous for an inactivated endogenous mGlu7 gene which exhibits symptoms of epileptic seizures.
    Type: Grant
    Filed: March 8, 1999
    Date of Patent: May 20, 2003
    Assignee: Novartis AG
    Inventor: Petrus Herman Maria Van der Putten
  • Patent number: 6504080
    Abstract: Animal model useful for testing potential therapeutic agents for the treatment of neurodegenerative disorders, in particular disorders associated with the presence of Lewy pathology.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: January 7, 2003
    Assignee: Novartis AG
    Inventor: Petrus Herman Maria Van Der Putten